Two analysts, one chromatogram, two answers
We work through a single chromatogram twice, under two integration conventions, and show where the difference comes from.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 7 of 7 of this archive, newest first.
We work through a single chromatogram twice, under two integration conventions, and show where the difference comes from.
What the Journal would want measured before treating this as settled in either direction.
Asymptomatic pancreatic enzyme elevation is common on treatment and is not pancreatitis. The distinction is clinical, not biochemical.
The result is unremarkable. What the report omits is not.
The evidence base is one secondary analysis, several small studies and a large amount of extrapolation from bariatric surgery.
The result is unremarkable. What the report omits is not.
A gel pack has a finite thermal budget, and once it is spent the payload equilibrates with whatever is outside the box. The only question is how long that takes.
A retest date says that material should be re-examined before use. An expiry date says it should not be used. The trade uses the second word for the first concept.
Every third-party report in this market describes a sample somebody chose to send. That choice is outside the laboratory’s control and outside its records.
A short audit procedure, usable by anyone holding a certificate and a calculator.
The supplier has not disputed the finding. It has not explained the gap either.
We submitted vials for endotoxin determination and report the results, the method and the laboratory, because a pyrogen figure without a method is as empty as a purity…
The header identifies the batch, the table records the tests, and the footer says who is answerable. Two of the three are usually incomplete.
What would make a difference is not a regulator. It is three lines on a certificate, all of which are already known to whoever wrote it.